Global Allergy Diagnostics and Therapeutics Market Size, Share, Analysis, Trends, 2032
Allergy Diagnostics and Therapeutics Market By Type (Diagnostics and Therapeutics), By Allergen Type (Food, Inhaled, Drug, and Other Allergens), By Test Type (In Vivo Test and In Vitro Test), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032
Category: Healthcare Report Format : PDF
Pages: 223 Report Code: ZMR-9177
Published Date: Jan-2025 Status : Published
| Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 33.5 Billion | USD 70.8 Billion | 8.7% | 2021 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Allergy Diagnostics and Therapeutics Market, (2024 - 2032) (USD Billion )
- 2.2 Global Allergy Diagnostics and Therapeutics Market : snapshot
- Chapter 3. Global Allergy Diagnostics and Therapeutics Market - Industry Analysis
- 3.1 Allergy Diagnostics and Therapeutics Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 The high prevalence of allergies drives market growth
- 3.3 Market Restraints
- 3.3.1. Complexity in allergy classification hinders market growth
- 3.4 Market Opportunities
- 3.4.1. Increasing product approval offers a lucrative opportunity for market growth
- 3.5 Market Challenges
- 3.5.1. The scarcity of qualified healthcare professionals poses a major challenge to market expansion
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Type
- 3.7.2 Market attractiveness analysis By Allergen Type
- 3.7.3 Market attractiveness analysis By Test Type
- Chapter 4. Global Allergy Diagnostics and Therapeutics Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Allergy Diagnostics and Therapeutics Market: company market share, 2023
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Allergy Diagnostics and Therapeutics Market - Type Analysis
- 5.1 Global Allergy Diagnostics and Therapeutics Market overview: By Type
- 5.1.1 Global Allergy Diagnostics and Therapeutics Market share, By Type, 2023 and 2032
- 5.2 Diagnostics
- 5.2.1 Global Allergy Diagnostics and Therapeutics Market by Diagnostics, 2024 - 2032 (USD Billion )
- 5.3 Therapeutics
- 5.3.1 Global Allergy Diagnostics and Therapeutics Market by Therapeutics, 2024 - 2032 (USD Billion )
- 5.1 Global Allergy Diagnostics and Therapeutics Market overview: By Type
- Chapter 6. Global Allergy Diagnostics and Therapeutics Market - Allergen Type Analysis
- 6.1 Global Allergy Diagnostics and Therapeutics Market overview: By Allergen Type
- 6.1.1 Global Allergy Diagnostics and Therapeutics Market share, By Allergen Type, 2023 and 2032
- 6.2 Food
- 6.2.1 Global Allergy Diagnostics and Therapeutics Market by Food, 2024 - 2032 (USD Billion )
- 6.3 Inhaled
- 6.3.1 Global Allergy Diagnostics and Therapeutics Market by Inhaled, 2024 - 2032 (USD Billion )
- 6.4 Drug
- 6.4.1 Global Allergy Diagnostics and Therapeutics Market by Drug, 2024 - 2032 (USD Billion )
- 6.5 Other Allergens
- 6.5.1 Global Allergy Diagnostics and Therapeutics Market by Other Allergens, 2024 - 2032 (USD Billion )
- 6.1 Global Allergy Diagnostics and Therapeutics Market overview: By Allergen Type
- Chapter 7. Global Allergy Diagnostics and Therapeutics Market - Test Type Analysis
- 7.1 Global Allergy Diagnostics and Therapeutics Market overview: By Test Type
- 7.1.1 Global Allergy Diagnostics and Therapeutics Market share, By Test Type, 2023 and 2032
- 7.2 In vivo Test
- 7.2.1 Global Allergy Diagnostics and Therapeutics Market by In vivo Test, 2024 - 2032 (USD Billion )
- 7.3 In vitro Test
- 7.3.1 Global Allergy Diagnostics and Therapeutics Market by In vitro Test, 2024 - 2032 (USD Billion )
- 7.1 Global Allergy Diagnostics and Therapeutics Market overview: By Test Type
- Chapter 8. Allergy Diagnostics and Therapeutics Market - Regional Analysis
- 8.1 Global Allergy Diagnostics and Therapeutics Market Regional Overview
- 8.2 Global Allergy Diagnostics and Therapeutics Market Share, by Region, 2023 & 2032 (USD Billion )
- 8.3. North America
- 8.3.1 North America Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 8.3.1.1 North America Allergy Diagnostics and Therapeutics Market, by Country, 2024 - 2032 (USD Billion )
- 8.3.1 North America Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 8.4 North America Allergy Diagnostics and Therapeutics Market, by Type, 2024 - 2032
- 8.4.1 North America Allergy Diagnostics and Therapeutics Market, by Type, 2024 - 2032 (USD Billion )
- 8.5 North America Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 - 2032
- 8.5.1 North America Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 - 2032 (USD Billion )
- 8.6 North America Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 - 2032
- 8.6.1 North America Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 - 2032 (USD Billion )
- 8.4. Europe
- 8.4.2 Europe Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 8.4.2.1 Europe Allergy Diagnostics and Therapeutics Market, by Country, 2024 - 2032 (USD Billion )
- 8.4.2 Europe Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 8.4 Europe Allergy Diagnostics and Therapeutics Market, by Type, 2024 - 2032
- 8.4.1 Europe Allergy Diagnostics and Therapeutics Market, by Type, 2024 - 2032 (USD Billion )
- 8.5 Europe Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 - 2032
- 8.5.1 Europe Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 - 2032 (USD Billion )
- 8.6 Europe Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 - 2032
- 8.6.1 Europe Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 - 2032 (USD Billion )
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 8.5.3.1 Asia Pacific Allergy Diagnostics and Therapeutics Market, by Country, 2024 - 2032 (USD Billion )
- 8.5.3 Asia Pacific Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 8.4 Asia Pacific Allergy Diagnostics and Therapeutics Market, by Type, 2024 - 2032
- 8.4.1 Asia Pacific Allergy Diagnostics and Therapeutics Market, by Type, 2024 - 2032 (USD Billion )
- 8.5 Asia Pacific Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 - 2032
- 8.5.1 Asia Pacific Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 - 2032 (USD Billion )
- 8.6 Asia Pacific Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 - 2032
- 8.6.1 Asia Pacific Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 - 2032 (USD Billion )
- 8.6. Latin America
- 8.6.4 Latin America Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 8.6.4.1 Latin America Allergy Diagnostics and Therapeutics Market, by Country, 2024 - 2032 (USD Billion )
- 8.6.4 Latin America Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 8.4 Latin America Allergy Diagnostics and Therapeutics Market, by Type, 2024 - 2032
- 8.4.1 Latin America Allergy Diagnostics and Therapeutics Market, by Type, 2024 - 2032 (USD Billion )
- 8.5 Latin America Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 - 2032
- 8.5.1 Latin America Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 - 2032 (USD Billion )
- 8.6 Latin America Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 - 2032
- 8.6.1 Latin America Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 - 2032 (USD Billion )
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 8.7.5.1 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by Country, 2024 - 2032 (USD Billion )
- 8.7.5 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 8.4 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by Type, 2024 - 2032
- 8.4.1 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by Type, 2024 - 2032 (USD Billion )
- 8.5 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 - 2032
- 8.5.1 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 - 2032 (USD Billion )
- 8.6 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 - 2032
- 8.6.1 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 - 2032 (USD Billion )
- Chapter 9. Company Profiles
- 9.1 R-Biopharm AG
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Thermo Fisher Scientific Inc.
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 DASIT Group SPA
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer Inc.)
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 AESKU.GROUP GmbH
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 bioMérieux
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Siemens Healthcare GmbH
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Stallergenes Greer
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 HYCOR Biomedical
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Minaris Medical America Inc.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Omega Diagnostics Group PLC
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Lincoln Diagnostics Inc.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 HOB
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Biotech Group Corp. Ltd.
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Danaher
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Alcon
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 AbbVie Inc.
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Sanofi
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Allergy Therapeutics
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Pfizer Inc.
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Teva Pharmaceutical Industries Ltd.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.22 GSK plc
- 9.22.1 Overview
- 9.22.2 Financials
- 9.22.3 Product Portfolio
- 9.22.4 Business Strategy
- 9.22.5 Recent Developments
- 9.23 and others.
- 9.23.1 Overview
- 9.23.2 Financials
- 9.23.3 Product Portfolio
- 9.23.4 Business Strategy
- 9.23.5 Recent Developments
- 9.1 R-Biopharm AG
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 4. Porter’s Five Forces Analysis
- 5. Global Allergy Diagnostics and Therapeutics Market attractiveness, By Type
- 6. Global Allergy Diagnostics and Therapeutics Market attractiveness, By Allergen Type
- 7. Global Allergy Diagnostics and Therapeutics Market attractiveness, By Test Type
- 8. Global Allergy Diagnostics and Therapeutics Market share by Type, 2024 and 2032 (USD Billion )
- 9. Global Allergy Diagnostics and Therapeutics Market by Diagnostics, 2024 - 2032 (USD Billion )
- 10. Global Allergy Diagnostics and Therapeutics Market by Therapeutics, 2024 - 2032 (USD Billion )
- 11. Global Allergy Diagnostics and Therapeutics Market share by Allergen Type, 2024 and 2032 (USD Billion )
- 12. Global Allergy Diagnostics and Therapeutics Market by Food, 2024 - 2032 (USD Billion )
- 13. Global Allergy Diagnostics and Therapeutics Market by Inhaled, 2024 - 2032 (USD Billion )
- 14. Global Allergy Diagnostics and Therapeutics Market by Drug, 2024 - 2032 (USD Billion )
- 15. Global Allergy Diagnostics and Therapeutics Market by Other Allergens, 2024 - 2032 (USD Billion )
- 16. Global Allergy Diagnostics and Therapeutics Market share by Test Type, 2024 and 2032 (USD Billion )
- 17. Global Allergy Diagnostics and Therapeutics Market by In vivo Test, 2024 - 2032 (USD Billion )
- 18. Global Allergy Diagnostics and Therapeutics Market by In vitro Test, 2024 - 2032 (USD Billion )
- 19. Global Allergy Diagnostics and Therapeutics Market share, by Region, 2024 and 2032
- 20. North America Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 21. Europe Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 22. Asia Pacific Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 23. Latin America Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
- 24. The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, 2024 - 2032 (USD Billion )
Table Of Tables
- 1. Global Allergy Diagnostics and Therapeutics Market: Snapshot
- 2. Drivers of the Allergy Diagnostics and Therapeutics Market: impact analysis
- 3. North America Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 4. North America Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 5. North America Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 6. U.S. Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 7. U.S. Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 8. U.S. Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 9. Canada Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 10. Canada Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 11. Canada Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 12. Europe Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 13. Europe Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 14. Europe Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 15. Germany Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 16. Germany Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 17. Germany Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 18. France Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 19. France Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 20. France Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 21. U.K. Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 22. U.K. Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 23. U.K. Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 24. Italy Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 25. Italy Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 26. Italy Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 27. Spain Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 28. Spain Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 29. Spain Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 30. Rest of Europe Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 31. Rest of Europe Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 32. Rest of Europe Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 33. Asia Pacific Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 34. Asia Pacific Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 35. Asia Pacific Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 36. China Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 37. China Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 38. China Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 39. Japan Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 40. Japan Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 41. Japan Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 42. India Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 43. India Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 44. India Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 45. South Korea Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 46. South Korea Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 47. South Korea Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 48. South-East Asia Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 49. South-East Asia Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 50. South-East Asia Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 51. Rest of Asia Pacific Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 52. Rest of Asia Pacific Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 53. Rest of Asia Pacific Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 54. Latin America Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 55. Latin America Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 56. Latin America Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 57. Brazil Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 58. Brazil Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 59. Brazil Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 60. Mexico Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 61. Mexico Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 62. Mexico Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 63. Rest of Latin America Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 64. Rest of Latin America Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 65. Rest of Latin America Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 66. The Middle-East and Africa Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 67. The Middle-East and Africa Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 68. The Middle-East and Africa Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 69. GCC Countries Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 70. GCC Countries Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 71. GCC Countries Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 72. South Africa Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 73. South Africa Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 74. South Africa Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
- 75. Rest of Middle-East Africa Allergy Diagnostics and Therapeutics Market revenue, By Type, 2024 - 2032 (USD Billion )
- 76. Rest of Middle-East Africa Allergy Diagnostics and Therapeutics Market revenue, By Allergen Type, 2024 - 2032 (USD Billion )
- 77. Rest of Middle-East Africa Allergy Diagnostics and Therapeutics Market revenue, By Test Type, 2024 - 2032 (USD Billion )
Methodology
FrequentlyAsked Questions
Allergy diagnostics refers to the methods and procedures applied to identify the exact allergens triggering a person to experience hypersensitive reactions and diagnose allergic diseases. Skin prick tests (SPT), blood tests, and patch testing are popular allergy diagnostics. Furthermore, allergy therapeutics center on controlling and curing allergic conditions by either immunotherapy or medication, lowering or eradicating symptoms.
The allergy diagnostics and therapeutics market is being driven by several factors, including the rising prevalence of infectious disease, increasing technological advancements, increasing geriatric population, and advancements in testing technology.
According to the report, the global allergy diagnostics and therapeutics market size was worth around USD 33.5 billion in 2023 and is predicted to grow to around USD 70.8 billion by 2032.
The global allergy diagnostics and therapeutics market is expected to grow at a CAGR of 8.7% during the forecast period.
The global allergy diagnostics and therapeutics market growth is expected to be driven by North America. It is currently the world’s highest revenue-generating market due to the growing prevalence of infectious diseases and the aging population.
The global allergy diagnostics and therapeutics market is dominated by players like R-Biopharm AG, Thermo Fisher Scientific, Inc., DASIT Group SPA, EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer, Inc.), AESKU.GROUP GmbH, bioMérieux, Siemens Healthcare GmbH, Stallergenes Greer, HYCOR Biomedical, Minaris Medical America, Inc., Omega Diagnostics Group PLC, Lincoln Diagnostics, Inc., HOB, Biotech Group Corp., Ltd., Danaher, Alcon, AbbVie, Inc., Sanofi, Allergy Therapeutics, Pfizer, Inc., Teva Pharmaceutical Industries Ltd. and GSK plc among others.
The allergy diagnostics and therapeutics market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed